PHARMA MAR, S.A. «12345...» Page 1 out of 11 from 01/07/1988 to 24/05/2018 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 24/05/2018 08:30 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings The Company sends notice of call, proposed resolutions and Directors´ Compensation Policy for 2019-2021 in relation to item Seven of the Agenda of the General Shareholders´ Meeting of Pharma Mar, S.A. Register number: 266065 18/05/2018 13:41 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings The Company announces the decision of the Board of Directors to call the Ordinary General Shareholders´ Meeting on June 27, 2018 and June 28, 2018, respectively, on the first and second call notice. Register number: 265813 27/04/2018 17:49 PHARMA MAR, S.A. Announcements of public presentations and meetings. - Strategic agreements with third parties Pharma Mar submits information regarding the termination of the licensing agreement for Japan entered into with Chugai in relation to Zepsyre. Register number: 264978 Related with 267170 of 26/06/2018 (18:02) 27/04/2018 07:45 PHARMA MAR, S.A. Credit ratings Axesor revises the rating of Pharma Mar, S.A. Register number: 264787 26/04/2018 17:52 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding the Q1 2018 results Register number: 264747 26/04/2018 17:46 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del primer trimestre de 2018 Register number: 264739 12/04/2018 17:47 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 11/01/2018 and 10/04/2018 Register number: 264033 12/04/2018 11:14 PHARMA MAR, S.A. Employees share and stock ownership schemes The Executive Committee of Pharma Mar, S.A. has decided to implement the Free of Charge Stock Ownership Plan approved by resolution of the Annual General Shareholders´ Meeting of 29 June 2017. Register number: 263991 Related with 254038 of 29/06/2017 (14:04) 21/03/2018 19:24 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks In relation to the Significant Fact n. 260272 the EMA has advanced to Pharma Mar that the CHMP confirms its negative Opinion issued in December 2017 in relation to Aplidin in the multiple myeloma indication. Register number: 263165 Related with 270099 of 02/10/2018 (08:14) 28/02/2018 18:20 PHARMA MAR, S.A. Board of directors remuneration annual statement La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2017 Register number: 262365 Page 1 out of 11 «12345...»